Impact of Structures from the Protein Structure Initiative  by Hendrickson, Wayne A.
Structure
OpinionsImpact of Structures from the
Protein Structure Initiative
Wayne A. Hendrickson1,2,*
1Howard Hughes Medical Institute
2Department of Biochemistry and Molecular Biophysics
Columbia University, New York, NY 10032, USA
*Correspondence: wayne@convex.hhmi.columbia.edu
DOI 10.1016/j.str.2007.11.006The collective efforts of the Protein
Structure Initiative (PSI) have so far
produced over 2700 protein structures
(http://kb.psi-structuralgenomics.org/
KB/, Metrics Module). This is an im-
pressive statistic, but what of interest
have we learned from these structures
and what might be the future impact
of this knowledge? In the case of
conventional structural biology, most
structural investigations are under-
taken in the context of substantial prior
knowledge about the subject mole-
cules; typically, the structural studies
are accompanied by functional analy-
ses inspired by structural results, and
the findings are published in papers
(although months or years after struc-
tures are solved). Here in the case of
PSI, and most notably so for the pro-
duction efforts of large-scale centers
of PSI-2, many of the subject mole-
cules are previously uncharacterized
and oftentimes they are not even an-
notated by homology.Moreover, apart
from collaborative efforts supported
with other funds, functional analyses
are outside the scope of PSI. Publica-
tion as a PDB deposition is immediate,
but papers appear for only a fraction
of the PSI structures. Thereby, out-
comes from this structural genomics
effort differ qualitatively from those
from conventional structural biology.
Although the majority of PSI struc-
tures are deposited without an accom-
panying publication, thePSI has never-
theless produced approximately 500
structural publications and a compara-
ble number ofmethodological publica-
tions (http://olenka.med.virginia.edu/
psi/). The structure papers are domi-
nated by straightforward descriptions
of the structures in relation to relevant
functional information from the litera-1528 Structure 15, December 2007 ª200ture, but a few also incorporate data
from functional experiments done in
a solicited collaboration (e.g., Mou-
gous et al., 2006; Forouhar et al.,
2007) or with other support to a PSI
laboratory (e.g., Yu et al., 2006). While
there are some abbreviated structure
notes, the bulk of PSI structure publi-
cations are full-fledged papers. Struc-
tures of unknown function typically
have only PDB deposits and no ac-
companying PSI publication, but such
structures are now being taken up for
study in the scientific community (see
below).
There are numerous examples ofPSI
results that compare with the output
from conventional structural biology,
and this is most evident from work on
biological themes and community-
nominated targets. But themain prem-
ise of the PSI venture, the very mission
of PSI-2, is the broader goal of provid-
ing a pan-genomic picture of protein
structures, using homology modeling
to flesh out sequence families. The ex-
plicit focus here is on novelty and the
work of large-scale centers is on those
families for which a representative
structure is not already available in
the PDB, thus many PSI-2 structures
are from families that have not here-
tofore been subjects of intense biolog-
ical investigation. Such PSI structures
therefore necessarily have greater
value prospectively than in explanation
of known biology, as in conventional
structural biology. The aim here is to
facilitate biological discovery rather
than only to follow it.
Despite the focus on prospective
uses of structure, analogous to pro-
spective uses of gene sequences, the
value of PSI structures is oftentimes
already evident from structural similar-7 Elsevier Ltd All rights reservedities that are cryptic in sequences,
from structural features evocative of
active sites, or from the presence of
adventitious ligands (37%of PSI struc-
tures contain a ligand). Such analyses
provide for structure-based assign-
ments of likely function (e.g., Jin
et al., 2006) or corrections of mistaken
annotations (e.g., Keller et al., 2002).
Indeed, the very existence of a protein
structure minimally moves the com-
monplace annotation of ‘‘hypothetical
protein’’ to ‘‘protein of unknown func-
tion’’. Moreover, irrespective of func-
tion, the very substantial contribution
of PSI structures to the universe of
novel structures (>40% of novel struc-
tures deposited into the PDB in Year 2
of PSI-2) is having an important impact
on understanding of the protein uni-
verse. Besides its intrinsic value, this
information also has utility in bioinfor-
matic identification of remote relation-
ships.
The ultimate aim for PSI structural
information is to provide a compre-
hensive and unencumbered basis for
future biological investigations. The
fruits of PSI are just beginning to be ex-
ploited in this manner, and a recently
reported study on a protein of un-
known function from Thermotoga mar-
itima (Tm0936) is perhaps a poster
child for this approach. Hermann
et al. (2007) studied this putative en-
zyme by first docking hypothetical
transition states of predicted sub-
strates and then testing the most
favorable substrate candidates in en-
zymatic assays and crystal structures.
Although a PSI participant performed
the confirmatory structure determina-
tion and a PSI lab provided a clone
to facilitate the work, this investiga-
tion was initiated as a completely
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sults. It is notable, however, that the
relevant PSI structures were depos-
ited in July 2002 and April 2003, but it
took until August 2007 for the resulting
publication to appear. Clearly, it will
take some time for the vast reservoir
of opportunity in the PSI Knowledge-
base to be fully realized.
As for sequence genomics, there is
a special value in structural complete-
ness. This cannot be managed in the
sameway for structures as for genome
sequences, of course, butwedoaspire
in the pan-genomic setting of PSI to
obtain representative structures for a
substantial portion of all sequences
from all of life. All of life, as we know it
fromsequences, is a rapidly expanding
entity with the recent flood of metage-
nomic data; this can complicate the
PSI effort, but it also presents excit-
ing opportunities and new structural
results relevant to human health are
now emerging from nascent PSI-2 ef-
forts on the human gut microbiome.
Despite the challenge, substantial in-
roads are also being made for specific
organisms. A recent paper describes
the progress in determinations of
structures from Mycobacterium tuber-
culosis (Baker, 2007), including a dom-
inant fraction from the TB Structural
Genomics Consortium started with
PSI-1. Similarly, led by the concerted
effort of another PSI-1 center, there
has been substantial movement to-
ward completeness of structures from
Thermotoga maritima, and the results
provide novel insight into metabolic
pathways and networks whereby, for
example, a new structural solution
emerged for an old function and this
provided a drug discovery opportunity
(Agrawal et al., 2004).
Beyond the overarching mission to
make atomic-level structural infor-
mation easily obtainable for most pro-teins from their corresponding DNA
sequences, the PSI also has a signifi-
cant component from biological theme
projects within the various centers and
from community-nominated targets.
These projects take advantage of
structural genomics approaches and
high-throughput infrastructure in the
centers, but many of these projects
have outcomes like those from con-
ventional structural biology. In addi-
tion, in the course of developing
approaches for addressing challeng-
ing targets such as membrane pro-
teins and eukaryotic proteins, PSI-2
specialized centers are also now
contributing structures of substantial
significance.
Finally, the structures of PSI have
brought with them advances in the
methods for protein production and
for structural analysis. These techno-
logical developments are an indirect,
but nevertheless substantial, benefit
from PSI structures. Enhanced tech-
nology improves efficiency for PSI,
reducing the cost per structure, but
much of this technology is also broadly
applicable to studies in individual labo-
ratories. Many of the advances are
improvements on ideas that pre-date
PSI (e.g., reductive methylation for
increased crystallization probability),
but the scale of PSI tests places con-
clusionsaboutefficacyonastatistically
sound basis freed from the tyranny of
anecdotal accounts. Other enabling
technologies (e.g., autoinduction for
protein expression) are directly attrib-
utable to PSI even though they are
already so engrained in general prac-
tice that PSI origins may be forgotten.
In sum, PSI structures have a multi-
faceted impact that is manifest at
present; but, and perhapsmore impor-
tantly, the comprehensive resource
that is being compiled also has a latent
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